Journal article icon

Journal article

A socially assistive robot to support mental wellbeing in LGBTQ+ young people at risk of self-harm: a randomized controlled trial

Abstract:
LGBTQ+ youth commonly have unmet mental health needs and are at elevated risk for self-harm, yet many face persistent institutional barriers to accessing support. One impactful way to reduce risk and promote wellbeing is by supporting emotion regulation; that is, the process by which individuals can influence which emotions they feel, when they feel them and how they experience or express these emotions. This universal, modifiable process is widely considered a key transdiagnostic target for mental ill-health prevention and intervention efforts. We conducted a randomized controlled trial using Purrble, a socially assistive robot designed to provide in-the-moment emotion regulation support through intuitive tactile interaction. Between 12 January and 1 September 2024, 153 LGBTQ+ youth with self-harm ideation were randomized 1:1 to receive Purrble and safety planning (Purrble + SP) or safety planning alone (SP-Only), stratified by gender identity (50.3% transgender/gender diverse). Data were collected over 13 weeks, with data collection closing on 22 October 2024. The primary outcome was perceived emotion regulation difficulties at follow-up, adjusted for baseline, gender identity and age. Participants allocated to the Purrble intervention reported fewer emotion regulation difficulties at follow-up than those allocated to safety planning alone (adjusted mean difference: –3.04; 95% confidence interval (CI): −4.92 to −1.16; P = 0.002; partial η2 = 0.07). For secondary outcomes, participants in the Purrble intervention also reported significantly lower symptoms of anxiety and depression, but no significant main effect was observed for self-harm. No serious Purrble-related adverse events were observed. Purrble may offer a scalable intervention to complement existing therapeutic approaches to support LGBTQ+ youth to enhance their emotion regulation. ClinicalTrials.gov: NCT06025942.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1038/s41591-026-04422-6

Authors

More by this author
Role:
Author
ORCID:
0000-0002-3987-3824
More by this author
Role:
Author
ORCID:
0000-0002-2728-9356
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Psychiatry
Sub department:
Psychiatry
Role:
Author
ORCID:
0000-0002-0365-7775


More from this funder
Funder identifier:
10.13039/501100000265
Grant:
RE23499


Publisher:
Nature Research
Journal:
Nature Medicine More from this journal
Volume:
32
Issue:
6
Pages:
2267-2276
Publication date:
2026-06-04
Acceptance date:
2026-04-24
DOI:
EISSN:
1546-170X
ISSN:
1078-8956


Language:
English
Keywords:
Source identifiers:
4245059
Deposit date:
2026-06-18
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP